Concepedia

Shannon McDonough

SM

22

Publications

1.7K

Citations

17

H-Index

2010

Active since

Affiliations

Fred Hutch Cancer Center(Current)

The Barbara Ann Karmanos Cancer Institute

Moffitt Cancer Center

Yale Cancer Center

Yale University

Shannon McDonough is an author at Fred Hutch Cancer Center specializing in oncology, medicine, and cancer research.

Top concepts

Publications per year

2010–2020

22

Publications

22

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

Scott Kopetz, Katherine A. Guthrie, Van K. Morris et al. · Journal of Clinical Oncology · 2020 · 381 citations · Full text

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip et al. · Journal of Clinical Oncology · 2019 · 314 citations · Full text

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy

Vincent Chung, Shannon McDonough, Philip A. Philip et al. · JAMA Oncology · 2016 · 173 citations · Full text

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518

James C. Yao, Katherine A. Guthrie, César A. Moran et al. · Journal of Clinical Oncology · 2017 · 161 citations · Full text

, , +16

Randomized trial of irinotecan and cetuximab with or without vemurafenib in <i>BRAF</i>-mutant metastatic colorectal cancer (SWOG 1406).

Scott Kopetz, Shannon McDonough, Van K. Morris et al. · Journal of Clinical Oncology · 2017 · 107 citations

, , +15

Rows per page

1–5 of 22